Creation of HalioDx MARSEILLE, France, March 23, 2015

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Creation of HalioDx

MARSEILLE, France, March 23, 2015 (GLOBE NEWSWIRE) -- A management buy-out by the QIAGEN Marseille Executive team

The ambition to become the reference diagnostic company in immuno-oncology

A business model combining immune companion diagnostics with biopharma and standalone developments

HalioDx, created from a management buy-out of QIAGEN Marseille, today announces its inception. HalioDx ambition is to become the reference company in immuno-oncology diagnostics, moving personalized medicine forward.

To achieve its ambition, HalioDx will from Day 1 combine three assets:

  • An experienced and complementary management team, cofounders of HalioDx. The team has a proven track record in all components of IVD oncology assays development and commercialization
  • Worldwide licences on a broad portfolio of patents on immuno-oncology biomarkers created by Inserm Transfert on behalf of Inserm, AP-HP and Paris-Descartes University. The inventions, developed by Jérôme Galon, Research Director at Inserm (cofounder of HalioDx and President of the Scientific Board) and his team (Inserm UMRS1138) at Cordeliers Research Center, Paris, France, comprise the Immunoscore® and several immune gene expression signatures. The Immunoscore® is an innovative combination of immunohistochemistry (with specific T lymphocytes markers) and digital pathology-based scoring 1 . It has been shown to significantly improve prognostication of colon cancer - a challenge for clinicians -, and is currently validated in a large international study 2 . The Immunoscore®, as well as gene expression signatures assessing multiple immune-related biomarkers currently under investigation, are promising candidates for predicting patient response to immuno-oncology treatments in several solid tumors
  • Fully operational R&D and manufacturing teams, and facilities and quality system

HalioDx will operate in the field of immuno-oncology, the most active today in oncology. Over the last 5 years, three immuno-oncology drugs - one anti-CTLA-4 and two anti-PD-1 molecules - have been approved in the US or in EU, for advanced melanoma and lung cancer, despite the absence of robust predictive biomarkers; many new molecules are in development by various biopharma companies. The IVD industry will play an essential role in accelerating the development of immunotherapies and their adoption in routine practice. Jérôme Galon and his team have been at the forefront of the development of immune-related assays and the concept of immune contexture. Nature, topography and intensity of the patient's immune reaction around his tumor are altogether key drivers of prognosis and of the potential to respond to immuno-oncology drugs. Work from other scientific groups supports this approach 3 .

HalioDx has raised 7.5 million euros in a Round A of financing combining the founders and three leading capital venture funds, MI Care, Sham Innovation Santé advised by Turenne Capital and Sofipaca. The first partner of HalioDx is today QIAGEN via manufacturing and R&D contracts. The company will leverage this relationship and others to come, to develop its proprietary offering in immuno-oncology diagnostics with the aim to classify tumors and guide individual treatment decisions.

HalioDx business model is based on 2 pillars:

  • Development of standalone assays, with the objective to obtain CE marking for the Immunoscore® in colon cancer within 18 months
  • Collaboration agreements with key biopharma players to develop and register immune companion diagnostics based on its portfolio of licenses.

"Inserm Transfert quickly realised that the technology Immunoscore® developed by Dr. J. Galon and his team had an outstanding potential in helping physicians to stratify cancer patients and support anti-cancer therapeutic approaches. Then we built the appropriate strategy (maturation, protection, commercialisation included) to allow its industrial transfer within the best possible conditions, all along in a trustful relationship with the academic team. We are very pleased to sign this licensing agreement with HalioDx, and delighted to contribute to its development and, in this regard, to the national ecosystem of innovation in human health." said Pascale Augé, CEO of Inserm Transfert.

"HalioDx is an ambitious entrepreneurial project" added Vincent Fert, President and Chief Executive Officer of HalioDx. " With our team of 75 people, we have the resources and collective expertise to drive diagnostic innovation in immuno-oncology, the most active field in oncology today. Considering the strength and scientific value of our worldwide license portfolio, and the need for powerful prognostic and predictive biomarkers in immuno-oncology, we are confident we will rapidly bring the Immunoscore® into routine clinical practice for colon cancer, and validate innovative predictive immune companion diagnostics for solid tumors. With these immune-related assays, we will contribute to a new dimension of personalized medicine in oncology, and support clinicians and patients to identify the optimal anti-cancer treatment strategy ."

About MICare

MICare is an investment holding specialized in health care. It follows Matignon Technologies 1 and 2, two funds which have supported for 11 years the current HalioDx leadership team in their previous responsibility as Ipsogen management team.  

About Sham Innovation Santé

Founded in May 2014, Sham Innovation Santé is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Santé's mission is to support innovative businesses in the health care sector through the growth and development phases of their life cycle.  

About Sofipaca

Sofipaca is the private equity branch of Crédit Agricole Alpes-Provence and Provence Côte d'Azur. Since its creation in 1984, Sofipaca supports Provence-Alpes-Côte d'Azur based businesses in their capital development and capital transmission projects. A long-term investor and minority shareholder, Sofipaca can support companies with different development profiles, and provides strategic input without interfering with operational management. 

Contacts
   
HalioDx Press relations: ATCG Press
Vincent Fert Judith Aziza
President and CEO Mob.:+33 (0)6 70 07 77 51
+ 33 (0)4 91 29 30 90 Marielle Bricman
vincent.fert@haliodx.com Mob.:+33 (0)6 26 94 18 53
  presse@atcg-partners.com
   
Helene Peyro-Saint-Paul, MD  
Vice-President,  
Medical and Corporate Affairs  
+ 33 (0)4 91 29 30 90  
helene.peyro-saint-paul@haliodx.com  

1 Galon et al, Science 2006, Mlecnik et al, JCO 2011

2 Galon et al, J Pathol 2014

3 Tumeh et al, Nature 2014, Llosa et al, Cancer Discov 2015

Creation of HalioDx http://hugin.info/168169/R/1905554/678151.pdf

HUG#1905554

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Clear Aligner Results Depend on Discipline, Not Hype

Updated Category News Views 130

A Clear Tray Is Not a Magic Wand Transparent orthodontic trays sell a wonderfully tidy idea: straighten teeth without the metal-and-wire routine, take them out to eat, and carry on. Fair enough. But the useful message from Dr. Theresa Trapp is the part nobody should glide past: clear aligners are a treatment plan, not a cosmetic shortcut bought with good intentions....

Continue Reading
Classic Chevrolet Gives $1.145M to 13 Local Groups

Updated Category News Views 104

A Thanksgiving Check With Some Real Weight More than a million dollars changing hands before lunch is not the usual holiday fluff, and Classic Chevrolet's planned $1,145,040 donation deserves more than a quick nod. On Tuesday, November 24, at 11 a.m. CST, the Grapevine dealership says it will distribute that sum among 13 nonprofit organizations and charitable programs...

Continue Reading
D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 55

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 45

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 76

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 115

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 108

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 67

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 50

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading

Top 5 Most Recently Viewed Articles

Digital Utilities Ventures Pioneers Sustainable Farming in Africa

Updated Category News Views 251

Transforming Agriculture with Easy FEN™ Technology Digital Utilities Ventures (DUTV) is making significant strides in sustainable agriculture with its Easy FEN™ modular units. Recently, the company secured a contract worth $3.4 million to deploy these innovative systems, targeting the challenges faced by farming communities in Africa. Sustainable Solutions Addressing...

Continue Reading
Prosafe SE Signs Contract with Ithaca Energy for Safe Caledonia

Updated Category News Views 203

Prosafe SE Secures Major Contract with Ithaca Energy Prosafe SE has recently finalized a significant contract with Ithaca Energy (UK) Limited regarding the operations of the Safe Caledonia. This agreement comes after a Letter of Intent was issued on July 5, 2024, marking a key step in their partnership and commitment to delivering essential accommodation support. The...

Continue Reading
Robert Half Acknowledged for Corporate Responsibility Excellence

Updated Category News Views 201

Recognizing Robert Half's Corporate Responsibility Achievements Global talent solutions and consulting giant Robert Half (NYSE: RHI) has recently received notable recognition from Newsweek, being named as one of America’s Most Responsible Companies for the year 2026. This award is a significant endorsement that highlights corporations that prioritize corporate social...

Continue Reading
Boeing's Job Cuts: Navigating Challenges in the Aerospace Sector

Updated Category News Views 190

Boeing's Significant Workforce Reductions Boeing has made headlines recently with its decision to cut approximately 2,200 jobs. This substantial reduction affects workers in various divisions, particularly in Washington. The downsizing comes as part of a larger strategy to trim about 17,000 positions as the aerospace company faces prolonged financial and operational...

Continue Reading
Exploring the Innovations of Horizon3.ai in Cybersecurity

Updated Category News Views 248

Introduction to Horizon3.ai's Autonomous Security Horizon3.ai has emerged as a pioneering force in the field of autonomous cybersecurity solutions, significantly shaping the landscape for security teams across the globe. The company, recognized for its innovative NodeZero Autonomous Security Platform, is dedicated to improving cyber resilience and enhancing the...

Continue Reading